Last update 26 Feb 2026

NKG2D-CAR-NK92 cells(Xinxiang Medical University)

Overview

Basic Info

Drug Type
CAR-NK
Synonyms-
Target
NKG2D
Action
antagonists
Mechanism
NKG2D antagonists(NKG2-D type II integral membrane protein antagonists), Immunologic cytotoxicity
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [3]
Active Indication
Breast CancerLung CancerMelanoma+ [4]
Inactive Indication-
Originator Organization
Henan Medical UniversityHenan Medical University
Active Organization
Henan Medical UniversityHenan Medical University
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NKG2D-CAR-NK92 cells(Xinxiang Medical University)
NCT05528341
/ RecruitingPhase 1IIT
Clinical Investigation of NKG2D-CAR-NK92 Chimeric Antigen Receptor Modified NK92 Cells in the Treatment of Relapsed/Refractory Solid Tumors
100 Clinical Results associated with NKG2D-CAR-NK92 cells(Xinxiang Medical University)
Login to view more data
100 Translational Medicine associated with NKG2D-CAR-NK92 cells(Xinxiang Medical University)
Login to view more data
100 Patents (Medical) associated with NKG2D-CAR-NK92 cells(Xinxiang Medical University)
Login to view more data
100 Deals associated with NKG2D-CAR-NK92 cells(Xinxiang Medical University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
Lung CancerPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
MelanomaPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
Ovarian CancerPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
Renal Cell CarcinomaPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
Stomach CancerPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
Uterine Cervical CancerPhase 1
China
Henan Medical UniversityHenan Medical University
26 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free